FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On September 28, 2007
Docket # Title
1978N-0038 Sunscreen Drug Products
1995S-0158 Community Disclosure of Institutional Review Boards
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1998D-0307 Exports/Imports under FDA export reform/enhancement Act 1996
2005P-0146 to establish guidance or regulations providing bioequivalence requirement for oral locally-acting gastrointestinal(GI) drug products prior to approval of any generic versions of such drugs
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
2007D-0249 Guidance for Industry: Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage
2007N-0321 Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
2007N-0330 Presidential Interagency Working Group on Import Safety; Public Meeting
2007P-0097 Issue a new regulation wine product the composition of wine , water, sugar, with or without flavorings and an alcohol content of less than 75% can not be marketed or sold with a wine varietal designa
2007P-0130 Seeking Immediate Approval of ANDA No. 78-226 for Amlodipine Besylate
2007P-0209 Not to grant final ANDA approval for any generic versions of Toprol-XL, metoprolol succinate extended-release tablets (metoprolol) 50, mg
2007P-0282 Require all products labels to include this information: Products % Costs Packaging: 80% Content: 20%
2007P-0297 Request to reconsider the failure to approve Provenge
2007P-0320 Regulation or Guideline to Label Medical Devices that Leach DEHP Plasticizers
2007P-0333 Strict and immediate enforcement of performance standards contained in: 21 CFR 10.20(g)(h) and 1020.33(c); 21 CFR 1040(h); 21 CFR 820.170 requiring manufacturers to supply all information for installa
2007P-0363 Prevent false and misleading labeling and ensure the safe and effacious use of dronibinol
1978N-0038 Sunscreen Drug Products
EC 2445 Dr. Angela Gilley Vol #: 161
EC 2446 Mrs. Felicia Czumble Vol #: 161
EC 2447 Ms. T Amar Vol #: 161
EC 2448 Miss. Minova Earle Vol #: 161
EC 2449 D. Miller Vol #: 161
1995S-0158 Community Disclosure of Institutional Review Boards
RPT 25 ROC Vol #: 1
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 20877 Enzymatic Vol #: 181
LET 20878 Enzymatic Vol #: 181
LET 20879 Enzymatic Vol #: 181
LET 20880 Enzymatic Vol #: 181
LET 20881 Enzymatic Vol #: 181
LET 20882 Natural Organics, Inc. Vol #: 181
LET 20883 Natural Organics, Inc. Vol #: 181
LET 20884 Natural Organics, Inc. Vol #: 181
LET 20885 Natural Organics, Inc. Vol #: 181
LET 20886 Natural Organics, Inc. Vol #: 181
LET 20887 Natural Organics, Inc. Vol #: 181
LET 20888 Natural Organics, Inc. Vol #: 181
LET 20889 Natural Organics, Inc. Vol #: 181
LET 20890 Natural Organics, Inc. Vol #: 181
LET 20891 Natural Organics, Inc. Vol #: 181
LET 20892 Natural Organics, Inc. Vol #: 181
LET 20893 NOW Foods Vol #: 181
LET 20894 NOW Foods Vol #: 181
LET 20895 NOW Foods Vol #: 181
LET 20896 NOW Foods Vol #: 181
LET 20897 Natural Organics, Inc. Vol #: 181
LET 20898 Shaklee Vol #: 181
LET 20899 Enzymatic Vol #: 181
LET 20900 Enzymatic Vol #: 181
LET 20901 Enzymatic Vol #: 181
LET 20902 Enzymatic Vol #: 181
LET 20903 Enzymatic Vol #: 181
LET 20904 Enzymatic Vol #: 181
LET 20905 Enzymatic Vol #: 181
LET 20906 Frutels, LLC Vol #: 181
LET 20907 PT Metrics LLC Vol #: 181
LET 20908 VitaGiant Laboratories, Inc. Vol #: 181
LET 20909 Market America, Inc. Vol #: 181
LET 20910 Market America, Inc. Vol #: 181
1998D-0307 Exports/Imports under FDA export reform/enhancement Act 1996
EC 61 Dr. A B Vol #: 1
2005P-0146 to establish guidance or regulations providing bioequivalence requirement for oral locally-acting gastrointestinal(GI) drug products prior to approval of any generic versions of such drugs
SUP 4 Salix Pharmaceuticals, Inc. Vol #: 1
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
EC 124 Agendia BV Vol #: 3
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
C 3192 S Severson Vol #: 30
C 3193 M Pappenfus Vol #: 30
C 3194 R Flood Vol #: 30
C 3195 A Garner Vol #: 30
C 3196 D Mix Vol #: 30
C 3197 J Stocks Vol #: 30
C 3198 E Hussin Vol #: 30
C 3199 R Hein Vol #: 30
C 3200 R Dunnam Vol #: 30
C 3201 D McGinnis Vol #: 30
C 3202 N Huckabee Vol #: 30
C 3203 K Schexnider Vol #: 30
C 3204 C Baisquet Vol #: 30
C 3205 E Jenerose Vol #: 30
C 3206 V Smith Vol #: 30
C 3207 B Fischer Vol #: 30
C 3208 C Davis Vol #: 30
C 3209 J Buck Vol #: 30
C 3210 A Harris Vol #: 30
C 3211 K Shipman Vol #: 30
C 3212 M Kettler Vol #: 30
C 3213 B Troup Vol #: 30
C 3214 J Tullo Vol #: 30
C 3215 H Daniels Sr Vol #: 30
C 3216 G Burger Vol #: 30
C 3217 H Stienstra Vol #: 30
C 3218 L Harbin Vol #: 30
C 3219 B Rogers Vol #: 30
C 3220 B Barnett Vol #: 30
C 3221 J Riehm Vol #: 30
C 3222 V Wagner Vol #: 30
C 3223 C Bernard Vol #: 30
C 3224 F Hester Vol #: 30
C 3225 C Thompson Vol #: 30
C 3226 P Townsley Vol #: 30
C 3227 B Cudo Vol #: 30
C 3228 M Baston Vol #: 30
C 3229 S Morgan Vol #: 30
C 3230 C Rice Vol #: 30
C 3231 B Borisoff Vol #: 30
C 3232 J Welpe Vol #: 30
C 3233 E Jackson Vol #: 30
C 3234 T Kidd Vol #: 30
C 3235 E Lanigan Vol #: 30
C 3236 B Harris Vol #: 30
C 3237 W O'Hara Vol #: 30
C 3238 T Prince Vol #: 30
C 3239 J Ley Vol #: 30
C 3240 J Plake Vol #: 30
C 3241 S Hale Vol #: 30
C 3242 R Orndorff Vol #: 30
C 3243 S Schnidt Vol #: 30
C 3244 D Rabasa Vol #: 30
C 3245 J Juliano Vol #: 30
C 3246 C Anderson Vol #: 30
C 3247 M Gibilterra Vol #: 30
C 3248 B Barwicks Vol #: 30
C 3249 F Del Buono Vol #: 30
C 3250 H Hoge Vol #: 30
C 3251 H Peyregne Vol #: 30
C 3252 M Petty Vol #: 30
C 3253 V Landes Vol #: 30
C 3254 L Cullen Vol #: 30
C 3255 S Schultz Vol #: 30
C 3256 R Dudek Vol #: 30
C 3257 R Phillips Vol #: 30
C 3258 J Baxter Vol #: 30
C 3259 M Osterberg Vol #: 30
C 3260 J Golden Vol #: 30
C 3261 B Critchell Vol #: 31
C 3262 Willson Vol #: 31
C 3263 L Williams Vol #: 31
C 3264 R Lynch Vol #: 31
C 3265 H Mendel Vol #: 31
C 3266 N Leggett Vol #: 31
C 3267 J Fales Vol #: 31
C 3268 P Menon Vol #: 31
C 3269 M Colyer Vol #: 31
C 3270 P TatgenHorst Vol #: 31
C 3271 L Ross Jr Vol #: 31
C 3272 G Anderson Vol #: 31
C 3273 H Roske Vol #: 31
C 3274 D Hemmes Vol #: 31
C 3275 D Rienbolt Vol #: 31
C 3276 B Wetters Vol #: 31
C 3277 M Gottlieb Vol #: 31
C 3278 L Cranek Vol #: 31
C 3279 K Galbraith Vol #: 31
C 3280 C Butterfield Vol #: 31
C 3281 J Gibbons Vol #: 31
C 3282 M Burrow Vol #: 31
C 3283 M Goodwin Vol #: 31
C 3284 J Downs Vol #: 31
C 3285 M Micalizzi Vol #: 31
C 3286 G Haynes Sr Vol #: 31
C 3287 B Chain Vol #: 31
C 3288 J Vandelinde Vol #: 31
C 3289 W Persinger Vol #: 31
C 3290 C Ploehn Vol #: 31
C 3291 R Zender Vol #: 31
C 3292 B Wagner Vol #: 31
C 3293 D Burford Vol #: 31
C 3294 M Garrett Vol #: 31
C 3295 J Smith Vol #: 31
C 3296 Dixie Pediatrics Vol #: 31
C 3297 T Adams Vol #: 31
C 3298 C Logan Vol #: 31
C 3299 D Kolander Vol #: 31
2007D-0249 Guidance for Industry: Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage
C 1 Zimmer Vol #: 1
2007N-0321 Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
EC 14 State University of New York at Stonybrook Vol #: 1
2007N-0330 Presidential Interagency Working Group on Import Safety; Public Meeting
EC 115 Mrs. Alice Potts Vol #: 1
EC 116 Steel Founders' Society of America Vol #: 1
EC 117 Philadelphia University Vol #: 1
EC 118 COTECNA, Inc. Vol #: 1
EC 119 VeritasAnalytics Inc Vol #: 1
EC 120 PakSense Inc. Vol #: 1
EC 121 Consumer Federation of America Vol #: 1
EC 122 Mr. gerald kucera Vol #: 1
EC 123 Mrs. Lenore Swanberg Vol #: 1
2007P-0097 Issue a new regulation wine product the composition of wine , water, sugar, with or without flavorings and an alcohol content of less than 75% can not be marketed or sold with a wine varietal designa
C 8 James R. Forrester Vol #: 1
C 9 Mitchella Vineyard & Winery Vol #: 1
C 10 Christine Andrus Vol #: 1
2007P-0130 Seeking Immediate Approval of ANDA No. 78-226 for Amlodipine Besylate
WDL 1 Zydus Pharmaceuticals (USA) Inc. Vol #: 1
2007P-0209 Not to grant final ANDA approval for any generic versions of Toprol-XL, metoprolol succinate extended-release tablets (metoprolol) 50, mg
EC 2 KV Pharmaceutical Company Vol #: 1
2007P-0282 Require all products labels to include this information: Products % Costs Packaging: 80% Content: 20%
EC 62 Dr. John Brady Vol #: 1
EC 63 Ms. Barbara Benton St. Gelais Vol #: 1
2007P-0297 Request to reconsider the failure to approve Provenge
EC 102 Mr. Randall Press Vol #: 1
EC 103 Mrs. Bonnie McGrath Vol #: 1
EC 104 Mr. Ernest Swauger Vol #: 1
EC 105 Mr. Steven Pintner Vol #: 1
EC 106 Mr. Mark Allen Vol #: 1
2007P-0320 Regulation or Guideline to Label Medical Devices that Leach DEHP Plasticizers
EC 1 Ms. Aquene Freechild Vol #: 1
EC 2 Miss. Genni Chandler Vol #: 1
EC 3 Oregon Center for Environmental Health Vol #: 1
EC 4 Mr. Mike Purvis Vol #: 1
EC 5 Mr. Ralph Markey Vol #: 1
EC 6 Magee-Womens Hospital of UPMC Vol #: 1
EC 7 Ms. Roberta Anderson Vol #: 1
EC 8 Portland State University Vol #: 1
EC 9 Mr. Terry Crossett Vol #: 1
EC 10 Ms. g murphy Vol #: 1
2007P-0333 Strict and immediate enforcement of performance standards contained in: 21 CFR 10.20(g)(h) and 1020.33(c); 21 CFR 1040(h); 21 CFR 820.170 requiring manufacturers to supply all information for installa
EC 1 Mr. gerald kucera Vol #: 1
2007P-0363 Prevent false and misleading labeling and ensure the safe and effacious use of dronibinol
ACK 1 FDA/DDM to Unimed Pharmaceuticals, Inc. Vol #: 1
CP 1 Unimed Pharmaceuticals, Inc. Vol #: 1

Page created on October 1, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management